Biopharmceutics Notes  from Maam Galagar
Upcoming SlideShare
Loading in...5
×
 

Biopharmceutics Notes from Maam Galagar

on

  • 752 views

This is from Maam Galagar. Thank you Ellaine Yeo for sharing this with me!

This is from Maam Galagar. Thank you Ellaine Yeo for sharing this with me!

Statistics

Views

Total Views
752
Views on SlideShare
752
Embed Views
0

Actions

Likes
0
Downloads
2
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Biopharmceutics Notes  from Maam Galagar Biopharmceutics Notes from Maam Galagar Document Transcript

  • Topic: Bioavailability & Bioequivalence Group 1: 1. Define the following terms: a. bioavailability b. bioequivalence c. bioequivalent drug products d. brand name e. chemical name f. drug product g. drug product selection h. generic name i. generic substitution j. pharmaceutic alternatives k. pharmaceutic equivalents l. pharmaceutic substitution m. therapeutic alternatives n. therapeutic equivalents o. therapeutic substitution 2. purpose of bioavailability studies Group 2: 1. discuss relative & absolute bioavailability 2. methods of assessing bioavailability 3. bases for determining bioavailability Group 3: 1. criteria for establishing a bioequivalence requirement 2. criteria for waiver of evidence of in vivo bioavailability 3. design & evaluation of bioequivalence studies Group 4: 1. clinical significance of bioequivalency studies 2. special concerns in bioavailability and bioequivalence studies The same grouping we had last meeting. We will start the reporting on tuesday, after the quiz. If you have any questions, just text me. Tnx! email me for confirmation. Margel Camille Luy-Galagar, RPh